Computed Tomography (CT) Based Lymphatic Mapping and Localization of Sentinel Lymph Node in Breast Cancer Patients
Phase 3
18 Years
70 Years
18 Years
70 Years
Open (Enrolling)
Both
Breast Cancer
Both
Breast Cancer
Trial Information
Computed Tomography (CT) Based Lymphatic Mapping and Localization of Sentinel Lymph Node in Breast Cancer Patients
Inclusion Criteria:
- Breast cancer patients（T1-T2N0）
- Age 18-70
- Accept of SLNB
- Accept our protocol in the informed consent
Exclusion Criteria:
- LABC patients
- Age < 18
- History of epilepsy
- History of thyrotoxicosis
- Pregnant women
Type of Study:
Interventional
Study Design:
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
all cause mortality
Outcome Time Frame:
five years
Safety Issue:
No
Authority:
China: Food and Drug Administration
Study ID:
FCW001
NCT ID:
NCT00952679
Start Date:
January 2009
Completion Date:
December 2011
Related Keywords:
- Breast Cancer
- The investigators evaluated the new method by comparing lymph nodes defined by CT and traditional ways.
- Breast Neoplasms
Name | Location |
|---|
